Tapewire

Nasdaq · USD

AURA

Aura Biosciences, Inc.

Export transactions ↓
Tapewire entity
5142
SEC CIK
0001501796
Parsed reports
136

Last 12 months

Inside the activity.

0 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202602
Feb 202605
Mar 202600
Apr 202601
May 202601
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 18, 2025 Filed Aug 18, 2025 20:34 UTC
Elazzouzi AmySenior Vice President, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 2,319 $0.00 Strike: $4.25 $0.00
Disclosure

SEC source: 0000950170-25-109767 · ownership.xml · derivative · entry 15

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,319 shares

Expires 2030-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option is fully vested.

Read SEC document
August 18, 2025 Filed Aug 18, 2025 20:34 UTC
Elazzouzi AmySenior Vice President, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 1,094 $0.00 Strike: $3.16 $0.00
Disclosure

SEC source: 0000950170-25-109767 · ownership.xml · derivative · entry 14

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,094 shares

Expires 2029-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option is fully vested.

Read SEC document
August 18, 2025 Filed Aug 18, 2025 20:34 UTC
Elazzouzi AmySenior Vice President, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 4,744 $0.00 Strike: $2.74 $0.00
Disclosure

SEC source: 0000950170-25-109767 · ownership.xml · derivative · entry 13

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,744 shares

Expires 2028-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option is fully vested.

Read SEC document
August 18, 2025 Filed Aug 18, 2025 20:34 UTC
Elazzouzi AmySenior Vice President, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 547 $0.00 Strike: $5.21 $0.00
Disclosure

SEC source: 0000950170-25-109767 · ownership.xml · derivative · entry 12

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 547 shares

Expires 2027-04-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option is fully vested.

Read SEC document
August 18, 2025 Filed Aug 18, 2025 20:34 UTC
Elazzouzi AmySenior Vice President, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 547 $0.00 Strike: $5.48 $0.00
Disclosure

SEC source: 0000950170-25-109767 · ownership.xml · derivative · entry 11

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 547 shares

Expires 2026-10-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option is fully vested.

Read SEC document
August 18, 2025 Filed Aug 18, 2025 20:34 UTC
Elazzouzi AmySenior Vice President, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 1,094 $0.00 Strike: $5.48 $0.00
Disclosure

SEC source: 0000950170-25-109767 · ownership.xml · derivative · entry 10

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,094 shares

Expires 2026-04-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option is fully vested.

Read SEC document
August 18, 2025 Filed Aug 18, 2025 20:34 UTC
Elazzouzi AmySenior Vice President, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 2,554 $0.00 Strike: $5.07 $0.00
Disclosure

SEC source: 0000950170-25-109767 · ownership.xml · derivative · entry 9

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,554 shares

Expires 2025-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option is fully vested.

Read SEC document
August 18, 2025 Filed Aug 18, 2025 20:34 UTC
Elazzouzi AmySenior Vice President, Finance
SaleCommon Stock 7,722 $6.70 $51,737.40
Disclosure

SEC source: 0000950170-25-109767 · ownership.xml · nonDerivative · entry 8

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,558

F1 · kind: On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.57 to $6.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 18, 2025 Filed Aug 18, 2025 20:34 UTC
Elazzouzi AmySenior Vice President, Finance
Exercise / conversionCommon Stock 2,319 $4.25 $9,855.75
Disclosure

SEC source: 0000950170-25-109767 · ownership.xml · nonDerivative · entry 7

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,280

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options.

Read SEC document
August 18, 2025 Filed Aug 18, 2025 20:34 UTC
Elazzouzi AmySenior Vice President, Finance
Exercise / conversionCommon Stock 1,094 $3.16 $3,457.04
Disclosure

SEC source: 0000950170-25-109767 · ownership.xml · nonDerivative · entry 6

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,961

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options.

Read SEC document
August 18, 2025 Filed Aug 18, 2025 20:34 UTC
Elazzouzi AmySenior Vice President, Finance
Exercise / conversionCommon Stock 4,744 $2.74 $12,998.56
Disclosure

SEC source: 0000950170-25-109767 · ownership.xml · nonDerivative · entry 5

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,867

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options.

Read SEC document
August 18, 2025 Filed Aug 18, 2025 20:34 UTC
Elazzouzi AmySenior Vice President, Finance
Exercise / conversionCommon Stock 547 $5.21 $2,849.87
Disclosure

SEC source: 0000950170-25-109767 · ownership.xml · nonDerivative · entry 4

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,123

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options.

Read SEC document
August 18, 2025 Filed Aug 18, 2025 20:34 UTC
Elazzouzi AmySenior Vice President, Finance
Exercise / conversionCommon Stock 547 $5.48 $2,997.56
Disclosure

SEC source: 0000950170-25-109767 · ownership.xml · nonDerivative · entry 3

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,576

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options.

Read SEC document
August 18, 2025 Filed Aug 18, 2025 20:34 UTC
Elazzouzi AmySenior Vice President, Finance
Exercise / conversionCommon Stock 1,094 $5.48 $5,995.12
Disclosure

SEC source: 0000950170-25-109767 · ownership.xml · nonDerivative · entry 2

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,029

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options.

Read SEC document
August 18, 2025 Filed Aug 18, 2025 20:34 UTC
Elazzouzi AmySenior Vice President, Finance
Exercise / conversionCommon Stock 2,554 $5.07 $12,948.78
Disclosure

SEC source: 0000950170-25-109767 · ownership.xml · nonDerivative · entry 1

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,935

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options.

Read SEC document
June 17, 2025 Filed Jun 18, 2025 20:10 UTC GrantStock Option (Right to Buy) · Derivative 17,000 $0.00 Strike: $6.18 $0.00
Disclosure

SEC source: 0000950170-25-087890 · ownership.xml · derivative · entry 5

Johnson David Michael · CIK 0001808098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,000

Underlying: Common Stock · 17,000 shares

Expires 2035-06-17

F5 · derivative.exercise_date: This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 17, 2025 Filed Jun 18, 2025 20:10 UTC GrantCommon Stock 13,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-087890 · ownership.xml · nonDerivative · entry 1

Johnson David Michael · CIK 0001808098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,167

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 17, 2025 Filed Jun 18, 2025 20:10 UTC GrantStock Option (Right to Buy) · Derivative 17,000 $0.00 Strike: $6.18 $0.00
Disclosure

SEC source: 0000950170-25-087889 · ownership.xml · derivative · entry 2

Mattessich Antony C. · CIK 0001709900 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,000

Underlying: Common Stock · 17,000 shares

Expires 2035-06-17

F2 · derivative.exercise_date: This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 17, 2025 Filed Jun 18, 2025 20:10 UTC GrantCommon Stock 13,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-087889 · ownership.xml · nonDerivative · entry 1

Mattessich Antony C. · CIK 0001709900 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,500

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 17, 2025 Filed Jun 18, 2025 20:10 UTC GrantStock Option (Right to Buy) · Derivative 17,000 $0.00 Strike: $6.18 $0.00
Disclosure

SEC source: 0000950170-25-087891 · ownership.xml · derivative · entry 2

Srivastava Sapna · CIK 0001569226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,000

Underlying: Common Stock · 17,000 shares

Expires 2035-06-17

F2 · derivative.exercise_date: This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 17, 2025 Filed Jun 18, 2025 20:10 UTC GrantCommon Stock 13,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-087891 · ownership.xml · nonDerivative · entry 1

Srivastava Sapna · CIK 0001569226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,500

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 16:05 UTC
de los Pinos ElisabetDirector · See Remarks
Exercise / conversionStock Option (Right to Buy) · Derivative 10,948 $0.00 Strike: $5.07 $0.00
Disclosure

SEC source: 0000950170-25-081615 · ownership.xml · derivative · entry 4

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,948 shares

Expires 2025-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were acquired and/or withheld to cover the exercise price and resulting tax obligations, as applicable, in connection with a net (cashless) exercise of stock options. The stock options subject to the net exercise were to expire June 2, 2025. These transactions were completed subsequent to the execution of a Lock-Up Agreement and the shares received are subject to the provisions of that agreement.

F3 · derivative.exercise_date: This option is fully vested.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 16:05 UTC
de los Pinos ElisabetDirector · See Remarks
Tax withholdingCommon Stock 9,948 $6.16 $61,279.68
Disclosure

SEC source: 0000950170-25-081615 · ownership.xml · nonDerivative · entry 2

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 483,440

F1 · kind: These shares were acquired and/or withheld to cover the exercise price and resulting tax obligations, as applicable, in connection with a net (cashless) exercise of stock options. The stock options subject to the net exercise were to expire June 2, 2025. These transactions were completed subsequent to the execution of a Lock-Up Agreement and the shares received are subject to the provisions of that agreement.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 16:05 UTC
de los Pinos ElisabetDirector · See Remarks
Exercise / conversionCommon Stock 10,948 $5.07 $55,506.36
Disclosure

SEC source: 0000950170-25-081615 · ownership.xml · nonDerivative · entry 1

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 493,388

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were acquired and/or withheld to cover the exercise price and resulting tax obligations, as applicable, in connection with a net (cashless) exercise of stock options. The stock options subject to the net exercise were to expire June 2, 2025. These transactions were completed subsequent to the execution of a Lock-Up Agreement and the shares received are subject to the provisions of that agreement.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:05 UTC
Gibney Anthony SSee Remarks
GrantStock Option (Right to Buy) · Derivative 250,000 $0.00 Strike: $6.16 $0.00
Disclosure

SEC source: 0000950170-25-081616 · ownership.xml · derivative · entry 2

Gibney Anthony S · CIK 0001750132 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2035-06-02

F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on May 13, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:05 UTC
Gibney Anthony SSee Remarks
GrantCommon Stock 150,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-081616 · ownership.xml · nonDerivative · entry 1

Gibney Anthony S · CIK 0001750132 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206,933

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on June 15, 2026, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
May 16, 2025 Filed May 20, 2025 21:43 UTC PurchaseCommon Stock Warrants (right to buy) · Derivative 5,000 Not disclosed Strike: $4.90 Not disclosed
Disclosure

SEC source: 0000950170-25-075412 · ownership.xml · derivative · entry 5

Johnson David Michael · CIK 0001808098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2030-05-16

F1 · kind: On May 16, 2025, the Reporting Person purchased 20,000 shares of the Issuer's common stock and a warrant to purchase 5,000 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering.

F1 · price: On May 16, 2025, the Reporting Person purchased 20,000 shares of the Issuer's common stock and a warrant to purchase 5,000 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering.

Read SEC document
May 16, 2025 Filed May 20, 2025 21:43 UTC PurchaseCommon Stock 20,000 $4.90 $98,000.00
Disclosure

SEC source: 0000950170-25-075412 · ownership.xml · nonDerivative · entry 1

Johnson David Michael · CIK 0001808098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,167

F1 · kind: On May 16, 2025, the Reporting Person purchased 20,000 shares of the Issuer's common stock and a warrant to purchase 5,000 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering.

Read SEC document
May 16, 2025 Filed May 20, 2025 21:34 UTC
Gibney Anthony SSee Remarks
PurchaseCommon Stock Warrants (right to buy) · Derivative 12,500 Not disclosed Strike: $4.90 Not disclosed
Disclosure

SEC source: 0000950170-25-075403 · ownership.xml · derivative · entry 3

Gibney Anthony S · CIK 0001750132 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2030-05-16

F1 · kind: On May 16, 2025, the Reporting Person purchased 50,000 shares of the Issuer's common stock and a warrant to purchase 12,500 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering.

F1 · price: On May 16, 2025, the Reporting Person purchased 50,000 shares of the Issuer's common stock and a warrant to purchase 12,500 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering.

Read SEC document
May 16, 2025 Filed May 20, 2025 21:34 UTC
Gibney Anthony SSee Remarks
SaleCommon Stock 1,519 $5.15 $7,822.85
Disclosure

SEC source: 0000950170-25-075403 · ownership.xml · nonDerivative · entry 2

Gibney Anthony S · CIK 0001750132 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,933

F2 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
May 16, 2025 Filed May 20, 2025 21:34 UTC
Gibney Anthony SSee Remarks
PurchaseCommon Stock 50,000 $4.90 $245,000.00
Disclosure

SEC source: 0000950170-25-075403 · ownership.xml · nonDerivative · entry 1

Gibney Anthony S · CIK 0001750132 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,452

F1 · kind: On May 16, 2025, the Reporting Person purchased 50,000 shares of the Issuer's common stock and a warrant to purchase 12,500 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering.

Read SEC document
April 16, 2025 Filed Apr 17, 2025 00:36 UTC
Kilroy ConorSee Remarks
SaleCommon Stock 7,162 $5.49 $39,319.38
Disclosure

SEC source: 0000950170-25-054953 · ownership.xml · nonDerivative · entry 1

Kilroy Conor · CIK 0001808510 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,313

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.48 to $5.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 16, 2025 Filed Apr 17, 2025 00:36 UTC
Elazzouzi AmySenior Vice President, Finance
SaleCommon Stock 897 $5.49 $4,924.53
Disclosure

SEC source: 0000950170-25-054954 · ownership.xml · nonDerivative · entry 1

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,381

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.49 to $5.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 20:02 UTC GrantStock Option (Right to Buy) · Derivative 29,000 $0.00 Strike: $5.86 $0.00
Disclosure

SEC source: 0000950170-25-049279 · ownership.xml · derivative · entry 2

Bitetti Teresa Marie · CIK 0001977608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,000

Underlying: Common Stock · 29,000 shares

Expires 2035-03-31

F2 · derivative.exercise_date: The shares underlying this option vest in three substantially equal annual installments beginning on March 31, 2026, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 20:02 UTC GrantCommon Stock 21,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-049279 · ownership.xml · nonDerivative · entry 1

Bitetti Teresa Marie · CIK 0001977608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,000

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in three substantially equal annual installments beginning on April 15, 2026, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
February 18, 2025 Filed Feb 19, 2025 00:31 UTC
Elazzouzi AmySenior Vice President, Finance
SaleCommon Stock 1,404 $7.75 $10,881.00
Disclosure

SEC source: 0000950170-25-022654 · ownership.xml · nonDerivative · entry 1

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,278

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
February 18, 2025 Filed Feb 18, 2025 19:30 UTC
de los Pinos ElisabetDirector · See Remarks
SaleCommon Stock 20,221 $7.75 $156,795.66
Disclosure

SEC source: 0000950170-25-022651 · ownership.xml · nonDerivative · entry 1

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 482,440

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.75 to $8.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 18, 2025 Filed Feb 19, 2025 00:30 UTC
Hopkins Janet JillChief Medical Officer
SaleCommon Stock 2,534 $7.75 $19,638.50
Disclosure

SEC source: 0000950170-25-022653 · ownership.xml · nonDerivative · entry 1

Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 269,794

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
February 18, 2025 Filed Feb 19, 2025 00:31 UTC
Plavsic MarkChief Technology Officer
SaleCommon Stock 2,151 $7.75 $16,670.25
Disclosure

SEC source: 0000950170-25-022655 · ownership.xml · nonDerivative · entry 1

Plavsic Mark · CIK 0001868719 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 209,456

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 22:51 UTC
Kilroy ConorSee Remarks
GrantStock Option (Right to Buy) · Derivative 59,525 $0.00 Strike: $7.68 $0.00
Disclosure

SEC source: 0000950170-25-013827 · ownership.xml · derivative · entry 2

Kilroy Conor · CIK 0001808510 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,525

Underlying: Common Stock · 59,525 shares

Expires 2035-02-02

F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 3, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 22:51 UTC
Kilroy ConorSee Remarks
GrantCommon Stock 90,475 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-013827 · ownership.xml · nonDerivative · entry 1

Kilroy Conor · CIK 0001808510 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,475

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2026, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 22:51 UTC
Elazzouzi AmySenior Vice President, Finance
GrantStock Option (Right to Buy) · Derivative 29,760 $0.00 Strike: $7.68 $0.00
Disclosure

SEC source: 0000950170-25-013825 · ownership.xml · derivative · entry 2

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,760

Underlying: Common Stock · 29,760 shares

Expires 2035-02-02

F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 3, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 22:51 UTC
Elazzouzi AmySenior Vice President, Finance
GrantCommon Stock 45,240 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-013825 · ownership.xml · nonDerivative · entry 1

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,682

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2026, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 17:52 UTC
de los Pinos ElisabetDirector · See Remarks
GrantStock Option (Right to Buy) · Derivative 255,680 $0.00 Strike: $7.68 $0.00
Disclosure

SEC source: 0000950170-25-013830 · ownership.xml · derivative · entry 3

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 255,680

Underlying: Common Stock · 255,680 shares

Expires 2035-02-02

F4 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 3, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 17:52 UTC
de los Pinos ElisabetDirector · See Remarks
GrantCommon Stock 194,320 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-013830 · ownership.xml · nonDerivative · entry 1

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 502,661

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2026, subject to the Reporting Person's continued service as of each such vesting date.

F2 · balance_after: On November 7, 2023, the Reporting Person filed a Form 4 which incorrectly included an additional 3,649 shares in the amount of securities beneficially owned directly after the reported transaction and excluded 3,649 shares from the amount of securities beneficially owned indirectly after the reported transaction. The Reporting Person's holdings after the transactions reported on this Form 4 reflect this correction.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 22:52 UTC
Plavsic MarkChief Technology Officer
GrantStock Option (Right to Buy) · Derivative 59,525 $0.00 Strike: $7.68 $0.00
Disclosure

SEC source: 0000950170-25-013829 · ownership.xml · derivative · entry 2

Plavsic Mark · CIK 0001868719 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,525

Underlying: Common Stock · 59,525 shares

Expires 2035-02-02

F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 3, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 22:52 UTC
Plavsic MarkChief Technology Officer
GrantCommon Stock 90,475 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-013829 · ownership.xml · nonDerivative · entry 1

Plavsic Mark · CIK 0001868719 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 211,607

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2026, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 22:51 UTC
Hopkins Janet JillChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 79,365 $0.00 Strike: $7.68 $0.00
Disclosure

SEC source: 0000950170-25-013828 · ownership.xml · derivative · entry 2

Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,365

Underlying: Common Stock · 79,365 shares

Expires 2035-02-02

F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 3, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 22:51 UTC
Hopkins Janet JillChief Medical Officer
GrantCommon Stock 120,635 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-013828 · ownership.xml · nonDerivative · entry 1

Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,328

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2026, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
January 21, 2025 Filed Jan 22, 2025 02:09 UTC
Elazzouzi AmyVice President, Finance
SaleCommon Stock 1,001 $7.67 $7,679.17
Disclosure

SEC source: 0000950170-25-007494 · ownership.xml · nonDerivative · entry 1

Elazzouzi Amy · CIK 0002042910 · Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,442

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.67 to $7.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.